E Fund Management Co., Ltd. Dyne Therapeutics, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.93 Billion
- Q3 2024
A detailed history of E Fund Management Co., Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 10,599 shares of DYN stock, worth $310,974. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,599
Previous 8,829
20.05%
Holding current value
$310,974
Previous $311,000
22.19%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
210Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$235 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$217 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$201 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$200 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$200 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.52B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...